655 - Long-term Safety and Efficacy of Delgocitinib Cream for Up to 36 Weeks in Adults with Chronic Hand Eczema: Results of the Phase 3 Open-Label Extension DELTA-3 Trial
British Journal of Dermatology（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined